Skip to main content
. 2022 Mar 10;15(9):1705–1712. doi: 10.1093/ckj/sfac073

Table 3.

Univariate Cox regression model depicting HR and 95% CI of baseline covariates associated with the risk of developing MACE in patients with CKD (n = 1142)

HR (95% CI) P
Sex (women) 0.69 (0.38–1.26) 0.231
Age (per year) 1.06 (1.03–1.09) 0.001
BMI (per kg/m2) 1.08 (1.03–1.13) 0.002
Smoking habit (current smoker) 1.38 (0.64–2.98) 0.412
Hypertension (yes) 21.3 (0.4–11 899.5) 0.342
Dyslipidemia (yes) 1.47 (0.77–2.83) 0.241
eGFR (per mL/min/1.73m2) 0.97 (0.95–0.99) 0.010
uACR (per mg/g) (n = 670) 1.00 (1.00–1.00) 0.065
Total cholesterol (per mg/dL) 1.00 (0.99–1.01) 0.663
LDL-C (per mg/dL) 1.00 (0.99–1.01) 0.965
HDL-C (per mg/dL) 0.97 (0.95–0.99) 0.033
Triglycerides (per mg/dL) 1.00 (1.00–1.00) 0.099
Statins (yes) 1.35 (0.75–2.46) 0.319
AS (per 1 point) 1.97 (1.21–3.21) 0.006
Fasting glucose (per mg/dL) 1.02 (1.00–1.05) 0.048
Hb1Ac (per 1%) 0.47 (0.17–1.25) 0.129
TyG (per unit) 1.95 (1.11–3.40) 0.018
TyG ≥ 8.63 2.29 (1.24–4.20) 0.008

Univariate regression Cox analysis for 4-point MACE as a dependent variable. TyG: triglycerides–glucose index; HR: hazard ratio; 95% CI: 95% confidence interval; uACR: urinary albumin–creatinine ratio; TyG = Ln (TG [mg/dL] × glucose [mg/dL]/2).